Key result
Bariatric surgery is linked to reduced subcutaneous fat cellularity, blood flow, and fatty acid uptake.
Why the study?
Body fat accumulation, distribution, and metabolic activity contribute to the pathophysiology of obesity and type 2 diabetes, but detailed understanding of adipose tissue blood flow and fatty acid uptake in these conditions is limited.
Does bariatric surgery alter adipose blood flow, fatty acid uptake, and fat cellularity in morbidly obese patients with or without type 2 diabetes?
Observational (n=38)
Does bariatric surgery alter adipose blood flow, fatty acid uptake, and fat cellularity in morbidly obese patients with or without type 2 diabetes?
Bariatric surgery reverses subcutaneous fat hyperplasia and hypertrophy while reducing absolute adipose tissue blood flow and fatty acid uptake in morbidly obese patients.
Bariatric surgery alters adipose FAU and flow in obesity; leaves open whether these changes drive metabolic benefits or require targeted trials.
Body fat accumulation, distribution, and metabolic activity are factors in the pathophysiology of obesity and type 2 diabetes (T2D). We investigated adipose blood flow, fatty acid uptake (FAU), and subcutaneous and visceral fat cellularity in obese patients with or without T2D. A total of 23 morbidly obese (mean body mass index = 42 kg/m2) patients were studied before and 6 mo after bariatric surgery; 15 nonobese subjects served as controls. Positron emission tomography was used to measure tissue FAU (with18F-FTHA) and blood flow (with H215O); MRI was used for fat distribution and fat biopsy for adipocyte size. Obese subjects had subcutaneous hyperplasia and hypertrophy and lower blood flow; when expressed per cell, flow was similar to controls. FAU into subcutaneous and visceral depots was increased in the obese; per unit tissue mass, however, FAU was similar to controls but reduced in skeletal muscle. Fatty acid fractional extraction in subcutaneous fat and muscle was only increased in obese patients with T2D. We conclude that surgery reduces subcutaneous fat hyperplasia and hypertrophy; subcutaneous blood flow and FAU decrease in absolute terms and per cell while fractional FAU remains unchanged in T2D. In the obese, subcutaneous blood flow is a determinant of FAU and is coupled with cellularity; efficiency of FAU is enhanced in subcutaneous fat and muscle in T2D.
No takes yet. Share an insight, caveat, or question.
Dadson et al. (2017) conducted an observational in Morbid obesity with or without type 2 diabetes (n=38). Bariatric surgery vs. Pre-surgery baseline and nonobese controls was evaluated on Adipose blood flow, fatty acid uptake (FAU), and fat cellularity. Bariatric surgery reduced subcutaneous fat hyperplasia and hypertrophy, and decreased subcutaneous blood flow and fatty acid uptake in absolute terms and per cell.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: